Abu Dhabi, UAE -- AstraZeneca has announced the launch of its revolutionary cancer medication, IMJUDO® (tremelimumab) in the UAE. The launch makes the UAE one of the first countries in the Middle East to receive access to the medication that marks a significant advancement in the treatment of cancer. Clinical...
tremelimumab
Google to invest $6.4bn
The investment is its biggest-ever in Germany.
Pfizer poised to buy Metsera
The pharma giant improved its offer to $10bn.
Ozempic maker lowers outlook
The company posted tepid Q3 results.
Kimberly-Clark to buy Kenvue
The deal is valued at $48.7 billion.
BYD Q3 profit down 33%
This was a 33% year-on-year decrease.
